Vanguard Asset Management
AGIO icon

Vanguard Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Vanguard Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
52,050
-6,598
-11% -$200K ﹤0.01% 1575
2026
Q1 		$1.98M Buy
+58,648
New +$1.66M ﹤0.01% 1469

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Vanguard Asset Management's AGIO Position: Q2 2026 in Review

Vanguard Asset Management reduced its Agios Pharmaceuticals (AGIO) stake by 11% in Q2 2026, selling an estimated $200K and leaving 52,050 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Vanguard Asset Management first reported a position in AGIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.98M in Q1 2026. 233 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Vanguard Asset Management held 52,050 shares of Agios Pharmaceuticals worth $1.93M as of Q2 2026.
  • Vanguard Asset Management sold 6,598 Agios Pharmaceuticals shares in Q2 2026, an estimated $200K.
  • Agios Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1575 holding.
  • Vanguard Asset Management first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Agios Pharmaceuticals position peaked at $1.98M in Q1 2026.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.